BioMarin Pharmaceutical | BMRN - Ebit

股票价格

55.95

每天变化

0.45 0.81%

每月一次

-8.10%

每年

-5.43%

Q2 预测

53.83

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.66B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	Ebit	更改		日
Acadia Pharmaceuticals	USD 17.39M		18.36M	2025-12
Agios Pharmaceuticals	USD -121.58M		4.71M	2025-12
Alnylam Pharmaceuticals	USD 29.4M		59.36M	2025-12
Amgen	USD 3.96B		464M	2025-12
Bayer	EUR 1.11B		1.51B	2025-12
Biogen	USD 659.6M		157M	2025-09
BioMarin Pharmaceutical	USD 198.39M		230.08M	2025-12
Gilead Sciences	USD 2.96B		551M	2025-12
Incyte	USD 383.88M		47.44M	2025-12
Insmed	USD -249.71M		11.64M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
Moderna	USD -857M		597M	2025-12
Neurocrine Biosciences	USD 227.9M		11.4M	2025-12
PTC Therapeutics	USD -81.62M		85.11M	2025-12
Puma Biotechnology	USD -2.2M		11.41M	2024-06
Regeneron Pharmaceuticals	USD 898.6M		211.3M	2025-12
Roche Holding	CHF 9.56B		2.1B	2025-12
Sanofi	EUR 3.74B		2.23B	2025-09
Sarepta Therapeutics	USD -410.08M		347.2M	2025-12
Ultragenyx Pharmaceutical	USD -114M		56.89M	2025-12
United Therapeutics	USD -14.6M		403.9M	2025-12
Vertex Pharmaceuticals	USD 1.26B		24.5M	2025-12